Yi-Hui Pan[Author] - Search Results

Year	Number of Results
2013	1
2017	2
2019	3
2020	1
2021	4
2023	2
2024	0

1

Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8⁺ T cell metabolic fitness and function in tumors.

Yang JF, Xing X, Luo L, Zhou XW, Feng JX, Huang KB, Liu H, Jin S, Liu YN, Zhang SH, Pan YH, Yu B, Yang JY, Cao YL, Cao Y, Yang CY, Wang Y, Zhang Y, Li J, Xia X, Kang T, Xu RH, Lan P, Luo JH, Han H, Bai F, Gao S. Yang JF, et al. Among authors: pan yh. Sci Immunol. 2023 Sep 29;8(87):eabq2424. doi: 10.1126/sciimmunol.abq2424. Epub 2023 Sep 22. Sci Immunol. 2023. PMID: 37738362

2

LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway.

Lu J, Fu LM, Cao Y, Fang Y, Cao JZ, Pan YH, Cen JJ, Liang YP, Chen ZH, Wei JH, Huang Y, Mumin MA, Xu QH, Wang YH, Zhu JQ, Liang H, Wang Z, Deng Q, Chen W, Jin XH, Liu ZP, Luo JH. Lu J, et al. Among authors: pan yh. Oncogene. 2023 May;42(19):1543-1557. doi: 10.1038/s41388-023-02666-x. Epub 2023 Mar 25. Oncogene. 2023. PMID: 36966254 Free PMC article.

3

Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis.

Huang KB, Pan YH, Shu GN, Yao HH, Liu X, Zhou M, Wei JH, Chen ZH, Lu J, Feng ZH, Chen W, Han H, Zheng ZS, Luo JH, Zhang JX. Huang KB, et al. Among authors: pan yh. Cancer Lett. 2021 Dec 28;523:121-134. doi: 10.1016/j.canlet.2021.10.003. Epub 2021 Oct 7. Cancer Lett. 2021. PMID: 34626691

4

A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma.

Gui CP, Cao JZ, Tan L, Huang Y, Tang YM, Li PJ, Chen YH, Lu J, Yao HH, Chen ZH, Pan YH, Ye YL, Qin ZK, Chen W, Wei JH, Luo JH. Gui CP, et al. Among authors: pan yh. Genomics. 2021 Mar;113(2):740-754. doi: 10.1016/j.ygeno.2021.01.016. Epub 2021 Jan 28. Genomics. 2021. PMID: 33516849 Free article.

5

Genetic risk classifier to predict localised renal cell carcinoma recurrence - Authors' reply.

Zhang JX, Pan YH, Lu J, Shu GN, Li PX, Li CX, Luo JH. Zhang JX, et al. Among authors: pan yh. Lancet Oncol. 2019 Jun;20(6):e288. doi: 10.1016/S1470-2045(19)30341-9. Lancet Oncol. 2019. PMID: 31162095 No abstract available.

6

Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis.

Zhang MX, Zhang LZ, Fu LM, Yao HH, Tan L, Feng ZH, Li JY, Lu J, Pan YH, Shu GN, Li PJ, Tang YM, Liao ZY, Wei JH, Chen W, Guo JP, Luo JH, Chen ZH. Zhang MX, et al. Among authors: pan yh. Oncogene. 2021 Sep;40(37):5639-5650. doi: 10.1038/s41388-021-01971-7. Epub 2021 Jul 28. Oncogene. 2021. PMID: 34321604 Free PMC article.

7

Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy.

Pan YH, Zhang JX, Chen X, Liu F, Cao JZ, Chen Y, Chen W, Luo JH. Pan YH, et al. Front Immunol. 2021 Aug 4;12:643282. doi: 10.3389/fimmu.2021.643282. eCollection 2021. Front Immunol. 2021. PMID: 34421886 Free PMC article.

8

Vanadium compounds induced damage of human umbilical vein endothelial cells and the protective effect of berberine.

Hou CC, Liang HY, Pan YH, Wang M, Zhao LL, Bian Y, Cao DY, Zhao D. Hou CC, et al. Among authors: pan yh. Biometals. 2019 Oct;32(5):785-794. doi: 10.1007/s10534-019-00211-6. Epub 2019 Sep 24. Biometals. 2019. PMID: 31552528

9

RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25.

Feng ZH, Fang Y, Zhao LY, Lu J, Wang YQ, Chen ZH, Huang Y, Wei JH, Liang YP, Cen JJ, Pan YH, Liao B, Chen W, Luo JH. Feng ZH, et al. Among authors: pan yh. Cancer Sci. 2017 Aug;108(8):1620-1627. doi: 10.1111/cas.13297. Epub 2017 Jul 3. Cancer Sci. 2017. PMID: 28612496 Free PMC article.

10

miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.

Lu J, Wei JH, Feng ZH, Chen ZH, Wang YQ, Huang Y, Fang Y, Liang YP, Cen JJ, Pan YH, Liao B, Chen WF, Chen W, Luo JH. Lu J, et al. Among authors: pan yh. Oncotarget. 2017 Mar 28;8(13):21461-21471. doi: 10.18632/oncotarget.15591. Oncotarget. 2017. PMID: 28423523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year